Posted on 04/07/2020 5:29:02 AM PDT by CheshireTheCat
In the Times’ latest attempt to “talk down” chloroquine, the journalists' ill-will to President Trump is on steroids. The article, entitled “Trump’s Aggressive Advocacy of Malaria Drug for Treating Coronavirus Divides Medical Community,” hauls out all of the usual critiques, including Dr. Fauci’s urging caution, Dr. Vladimir Zelenko’s being “a hit on conservative media,” the fact that Zelenko was born in Ukraine, and the Zelenko-Giuliani connection (cue the ominous music).
Those criticisms, though, are getting stale, so this time around, the Times threw in something new: It hinted that Trump and his cronies are about to get rich off of hydroxychloroquine.
(Excerpt) Read more at americanthinker.com ...
This story proves that the NYT simply makes up its news about the President, proving it’s ALL fake. HCQ is generic and has been around for well over half a century. There are dozens of manufacturers, making millions of doses, and a complete regimen of it costs around 20 bucks. That includes profits, packaging, distribution, warehousing, patient specific labelling, pharmacist fees, and more. Either the NYT thinks the entire population is all dumber than a bag of hammers, or they themselves are. The latter is the only possible conclusion.
Or, hey presstitutes...how about Pelosi who bought amazon stock in January?
I would like to see President Trump say all of what you said today...and then ask the presstitutes to research what stocks ALL congress critters bought or sold in January after their “briefings.”
How long a time period does Trump have to sue these idiots for Libel???
The World has a financial stake in it....
Today’s talking point. The crisis is curving so the left is adjusting BS insane propaganda.
Per the NYT a man could retire on that kind of money.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.